Newtricious BV   Report issue

For profit
Founded: Hertogenbosch Netherlands (1956)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2007
NCT00527553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Newtricious

Active Ingredients

Drugs in Other Trials (1)

egg (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1